US 10335391
Stabilized oxymetazoline formulations and their uses
granted A61KA61K31/4164A61K31/4174
Quick answer
US patent 10335391 (Stabilized oxymetazoline formulations and their uses) held by Aclaris Therapeutics, Inc. expires Mon Jun 27 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aclaris Therapeutics, Inc.
- Grant date
- Tue Jul 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 27 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 37
- CPC classes
- A61K, A61K31/4164, A61K31/4174, A61K47/10, A61K47/12